Drug Shortage Report for LAMICTAL
Report ID | 43073 |
Drug Identification Number | 02142104 |
Brand name | LAMICTAL |
Common or Proper name | Lamotrigine tablets |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | LAMOTRIGINE |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100's |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2018-05-11 |
Estimated end date | 2018-06-08 |
Actual end date | 2018-05-25 |
Shortage status | Resolved |
Updated date | 2018-05-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-05-26 | English | Compare |
v9 | 2018-05-25 | French | Compare |
v8 | 2018-05-25 | English | Compare |
v7 | 2018-05-12 | English | Compare |
v6 | 2018-05-11 | French | Compare |
v5 | 2018-05-11 | English | Compare |
v4 | 2018-03-28 | French | Compare |
v3 | 2018-03-28 | English | Compare |
v2 | 2018-03-16 | French | Compare |
v1 | 2018-03-16 | English | Compare |
Showing 1 to 10 of 10